Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Seladelpar in Subjects With Hepatic Impairment and Healthy Subjects
Clinical trial NCT03369002 · COMPLETED
Trial details
- NCT number
- NCT03369002
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-27
- Primary completion
- 2018-05-15
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.